SERBP1
SERPINE1 mRNA-binding protein 1
Also known as: CGI-55, CHD3IP, DKFZP564M2423, HABP4L, PAI-RBP1, PAIRBP1, SERB1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NC51
- Gene
- SERBP1
- Ensembl
- ENSG00000142864
- Chromosome
- 1
- Canonical length
- 408 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
Enables several functions, including SUMO binding activity; mRNA 3'-UTR binding activity; and ribosome binding activity. Involved in PML body organization and ribosome hibernation. Located in cytosol and nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
408 residues, UniProt reviewed canonical sequence.
>Q8NC51|SERBP1
1 MPGHLQEGFG CVVTNRFDQL FDDESDPFEV LKAAENKKKE AGGGGVGGPG AKSAAQAAAQ
61 TNSNAAGKQL RKESQKDRKN PLPPSVGVVD KKEETQPPVA LKKEGIRRVG RRPDQQLQGE
121 GKIIDRRPER RPPRERRFEK PLEEKGEGGE FSVDRPIIDR PIRGRGGLGR GRGGRGRGMG
181 RGDGFDSRGK REFDRHSGSD RSSFSHYSGL KHEDKRGGSG SHNWGTVKDE LTESPKYIQK
241 QISYNYSDLD QSNVTEETPE GEEHHPVADT ENKENEVEEV KEEGPKEMTL DEWKAIQNKD
301 RAKVEFNIRK PNEGADGQWK KGFVLHKSKS EEAHAEDSVM DHHFRKPAND ITSQLEINFG
361 DLGRPGRGGR GGRGGRGRGG RPNRGSRTDK SSASAPDVDD PEAFPALALocalizationUniProt · AlphaFold · HPA
Whether an antibody against SERBP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.68
- Highest tissue expression
- 316 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 316 nTPM
- esophagus: 163 nTPM
- tongue: 149 nTPM
- skin: 131 nTPM
- parathyroid gland: 124 nTPM
- bone marrow: 123 nTPM
Single-cell type
- esophageal basal cells: 872 nCPM
- late primary spermatocytes: 863 nCPM
- erythrocyte progenitors: 863 nCPM
- esophageal suprabasal cells: 842 nCPM
- suprabasal keratinocytes: 830 nCPM
- basal keratinocytes: 767 nCPM
Immune cell
- NK-cell: 148 nTPM
- T-reg: 132 nTPM
- MAIT T-cell: 126 nTPM
- total PBMC: 119 nTPM
- naive CD4 T-cell: 115 nTPM
- myeloid DC: 108 nTPM
Brain region
- medulla oblongata: 91 nTPM
- white matter: 90 nTPM
- spinal cord: 89 nTPM
- thalamus: 88 nTPM
- pons: 85 nTPM
- basal ganglia: 83 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.18
- gnomAD pLI
- 1
- gnomAD missense Z
- 1.67
- DepMap mean gene effect
- -0.54
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of translation
- PML body organization
- regulation of mRNA stability
- ribosome hibernation
Molecular functions
- cadherin binding
- mRNA 3'-UTR binding
- ribosome binding
- RNA binding
- SUMO binding
- translation elongation factor binding
- translation repressor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SERBP1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SERBP1 as an antibody target. Whether an autoantibody or antibody against SERBP1 could matter depends on whether native SERBP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SERBP1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SERBP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...